Cape Verde vs France: New cases tested for RR-/MDR-TB
Cape Verde
4.3%
in 2024
France
1.8%
in 2024
Cape Verde rank
180th
France rank
182nd
New cases tested for RR-/MDR-TB over time
- Cape Verde
- France
How they compare
Cape Verde currently reports 4.3% against 1.8% in France, a difference of 2.5%.
That makes Cape Verde's figure about 2.4 times France's.
The two have swapped places 3 times across 14 shared years of data; in 2008 it was France ahead.
Cape Verde ranks 180th and France ranks 182nd of 192 countries.
Across the 3 decades both report, Cape Verde averaged higher in 1 and France in 2.
Head to head by decade
| Decade | Cape Verde | France | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 100.0% | 100.0% | France |
| 2010s | 28.4% | 81.9% | 53.6% | France |
| 2020s | 43.9% | 1.9% | 42.0% | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Cape Verde or France?
- Cape Verde, at 4.3% against 1.8% in France as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Cape Verde and France?
- 2.5%, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and France?
- 14 years are reported by both, from 2008 to 2024.
- How do Cape Verde and France rank globally for new cases tested for rr-/mdr-tb?
- Cape Verde ranks 180th and France ranks 182nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.